Cell Culture Media Market Research report forecast to 2023

Cell Culture Media Market Research report forecast to 2023

ID: MRFR/HC/3049-CRR | September, 2018 | Region: Global | 110 pages | Cooked Research Reports

Global Cell Culture Media Market Research Report, by Type (Lysogeny Broth, Classical Media, Custom Media, Other), by Application (Drug Discovery, Toxicity Testing, Other), by End-user (Biotechnology & Pharmaceutical Companies) - Global Forecast Till 2023


Cell culture medium is usually a liquid or gel designed to encourage the growth of microorganisms, cell lines, and cells. The medium contains amino acids, inorganic salts, vitamins, glucose, serum, and other vital nutrients for successfully growing various types of cells. The global cell culture media market is touted to exhibit a healthy 9.1% CAGR during the assessment period (2017-2023), as per a new market report by Market Research Future (MRFR).


The progress witnessed in stem cell research, biopharmaceuticals, and oncology is the major driver of the cell culture medium market. Emergence of various biotech startups and contract research organizations mushrooming to meet the demand for biopharmaceutical products can boost the market demand in the coming years. Rise in research and development (R&D) expenditure of various companies can augur the market as well. Lax policies regarding stem cell studies in developing economies is anticipated to boost the market demand. But challenges remain in the form of high costs of culture media, standardization, and chances of contamination.


Report Overview


The report covers the latest trends impacting the market to provide the most accurate forecasts and predictions. By correlating the historical data with upcoming market dynamics, our analysts can make highly astute projections. MRFR’s report includes a thorough analysis of the global cell culture media market segmented according to type, application, end-user, and region. Growth opportunities are highlighted coupled with the market share of companies as well as their valuation in the market. It analyzes new revenue sources for players and outlines the various strategies implemented by players.


Segment Overview


By type, the cell culture media market is segmented into chemically defined media, serum free media, protein free media, classical media, custom media, and lysogeny broth. Key market applications include stem cell research, genetic engineering, tissue engineering & biochemistry, toxicity testing, cancer research, and drug discovery & drug development. By end-user, the market is segmented into research laboratories, pathology labs, academic institutes, and biotechnology & pharmaceutical industries.


The segments covered in the report are analyzed with respect to four major regions – Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. The definition of “cell culture media” is outlined in the report for a comprehensive understanding of the market. The report discusses in detail the various players and their respective strategies to enhance their value chain.


Competitive Landscape


Some of the key players in the cell culture media market include HiMedia Laboratories (India), Thermo Fisher Scientific (U.S.), BD Biosciences (U.S.), Lonza (Switzerland), Corning Incorporated (U.S.), Merck KGaA (Germany), and GE Healthcare (U.S.). These players are engaged in partnerships to launch new products in the market and expand their consumer base. In 2017, GE Healthcare and the Austrian Center of Industrial Biotechnology collaborated to produce a cell line.


The report offers comprehensive profiles on these market players and assesses their current standing in the market. Company history coupled with annual turnover, profit margins, segmental share, SWOT analysis, growth strategies, new product launches, mergers and acquisitions (M&A) activities, and latest R&D initiatives are discussed in granular detail.


Research Methodology


At MRFR, our research analysts conduct a thorough objective analysis of the market when creating market reports by adhering to a rigorous set of standards which allow a truly comprehensive view of the market. Use of primary research strategies such as interviews with top-level decision makers of various biopharmaceutical companies and cell culture supply companies combined with secondary research provides a thorough analysis of past and present trends in a forward-looking manner. Additionally, market size estimation and validation use both top-down & bottom-up approaches to obtain data from the demand and supply-side. Credible resources are employed to assist analysts to understand the nuances of market factors with consistency. Competent data analysts use strong analytical tools to ascertain accurate analysis of very relevant parameters in an effort to provide clients with a conclusive and dependable view of the future.


Analysis Period



  • Base Year - 2016

  • Projection Period - From 2017 to 2023

  • Market Denomination - USD Million

  • Conversion Rate - Considered as per the respective financial years


For the scope of research, the report offers a comprehensive analysis of the global cell culture media market.


Type



  • Lysogeny Broth

  • Chemically Defined Media

  • Protein Free Media

  • Classical Media

  • Serum Free Media

  • Custom Media


Application



  • Drug Discovery & Drug Development

  • Toxicity Testing

  • Cancer Research

  • Stem Cell Research

  • Genetic Testing

  • Tissue Engineering & Biochemistry


End-user



  • Biotechnology & Pharmaceutical Companies

  • Research Laboratories

  • Academic Institutes

  • Pathology Labs


Region



  • Americas

    • North America

      • The U.S.

      • Canada



    • South America





  • Europe

    • Western Europe

      • France

      • The U.K.

      • Germany

      • Italy

      • Spain

      • Rest of Western Europe



    • Eastern Europe





  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia Pacific





  • Middle East & Africa

    • Qatar

    • Oman

    • Kuwait

    • Saudi Arabia

    • United Arab Emirates

    • Rest of Middle East & Africa




Intended Audience



  • Medical Devices Companies

  • Research and Development (R&D) Companies

  • Government Research Institutes

  • Academic Institutes and Universities

Cell Culture Media Market – Summary


The significant impact of the advancing technologies on life science has developed methods through which cells can now be cultured in artificial mediums. Cells, tissues or organs are obtained generally from plants or animals and are given conducive environment in which they can grow and deliver desired results. Usually, the medium consists amino acids, vitamins, inorganic salts, glucose, and serum that act as a spring of growth factors, hormones, and attachment factors and the aim is to maintain the pH level and osmolality. Its widespread use in laboratories for research purposes, in pharmaceutical to develop new medicines and significant impact on the cost-cutting measures of several sectors have made this a market favorite. The global cell culture media market can now envision a leap from USD 703.1 million to USD 1290.1 million during the forecast period (2017-2023).


The stellar CAGR of 9.1% can be attributed to mainly biotechnology sector where increasing investment by the government and private players are assisting in research and development activities. Researches are primarily aimed at producing vaccines to curb the effects of various diseases. In India, as per the India Brand Equity Foundation, the said industry is accounted for USD 11 billion in 2016. On the other hand, new bio firms are mushrooming all across the globe who can generate the demand for cell culture media market considerably.


However, the research process incurs a high cost, and the chance of medium getting contaminated due to serum and a poor source of animal components can adversely impact the market. On the flip side, manufacturing base in emerging countries such as India and China costs surprisingly less than other regions in the world which can steer the market away from such deterrents. Furthermore, labor-intensive production activities, if shifted to low wage and low regulatory regions, can fetch in economic incentives. And in such scenarios, India and China shine the best. These countries can promise a reduction in expenditure by almost 33% which is quite outstanding.


Segmental Analysis:


Type-based segmentation of the market includes lysogeny broth, chemically defined media, protein-free media, serum-free media, classical media, and custom media. Lysogeny broth with a 22.5% share of the global market is reigning supreme. Meanwhile, chemically defined media is showing prospects using which it can attain the fastest CAGR of 9.6% during the forecast period.    


Application-wise the market consists drug discovery and drug development, toxicity testing, cancer research, genetic engineering, tissue engineering & biochemistry, and stem cell research. Drug discovery and drug development segment with about 23.8% of the market share is doing impressive work. Prevalence of cancer in many countries has inspired the cancer research segment into work harder which is why with a 9.7% CAGR this segment can grow during the review period.


Based on end-user, the market can be segmented into biotechnology & pharmaceutical companies, research laboratories, academic institutes, and pathology labs. Biotechnology & pharmaceutical companies have fetched in the largest share of the market and have a prospect to earn around USD 386.5 million by 2023. Demand for vaccines is giving the sub-segment much traction. Government and multinational initiatives are ensuring setups of research laboratories which can witness the fastest growth rate of CAGR 9.3% during the assessment period.


Regional Analysis:


Geographic segmentation of the market reveals regions such as the Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA).


The Americas financially contribute the most to the global valuation of the market. The region has a superlative infrastructure for research and developments banking on which the market is skyrocketing with a prospect to soar even higher in the foreseeable future. A massive patient pool, suffering from various chronic diseases are also a major driver for the regional growth of the market.


The European market has several nations contributing substantially to the growth of the market such as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Government initiatives in this region are noteworthy and commendable, at the same time, the market is all set to attain better treatment procedures which are triggering further growth.


The APAC market with several nations such as Japan, China, India, Australia, and South Korea promise a better-envisioned picture. The region has India and China who are attracting players from all over the world with their lucrative setup offers that can increase the profit margin of the investors sizably. Developing economies, and increasing number of efficient labors are playing significant roles in the region delivering the best of the results due to which the fastest CAGR seems reasonably expected.


Market Dashboard:


Key players influencing the market are Thermo Fisher Scientific, Merck KGaA, and GE Healthcare. Strategic partnerships, collaboration, and new product launches are methods opted by many to strengthen their market position. For instance, in July 2015, Corning Incorporated launched HepatoCells followed by a distribution agreement with BioCision, LLC for its cell cryopreservation portfolio in November 2015.


Merck KGaA engages itself in regional expansion and new product launches to widen its market presence. As a result, in May 2017, Merck launched Industry’s first off-the-shelf cell culture media for perfusion processes.


GE Healthcare, on the other hand, in February 2017, started collaborating with the Austrian Centre of Industrial Biotechnology.


Among the others, Lonza, BD, HiMedia Laboratories, Corning Incorporated are prominent players in the market. PeproTech GmbH, Bio Elpida, ProBioGen are doing significant business.

License
Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency
TABLE OF CONTENTS

2.1 Scope of Study 15

2.2 Research Objective 15

2.3 Assumptions & Limitations 16

2.3.1 Assumptions 16

2.3.2 Limitations 16

2.4 Market Structure 16

3.1 Introduction 17

3.2 Primary Research 18

3.3 Secondary research 18

3.4 Market Size Estimation 19

4.1 Drivers 21

4.1.1 Rise in demand for cell culture media will boost the growth globally (Impact weightage 40%) 21

4.1.2 CRO to benefit the market because of competition, economics of production and trade, specialization (Impact weightage – 25%) 22

4.1.3 Rising research and development and number of biotech start-ups will boost the demand due to better product development and increasing capacity (Impact weightage – 35%) 23

4.2 Restraints 24

4.2.1 Standardization and interoperability issues (Impact weightage – 55%) 24

4.2.2 Cost of cell culture media and contamination of media is a threat to the growth of the market (Impact weightage -45%) 25

4.3 Opportunities 26

4.3.1 Research and development 26

4.3.2 Personalization and customization 26

4.3.3 Developing regions as a base for production 26

4.4 Challenges 26

4.4.1 Growth in exposure to natural and man-made threats 26

4.5 Macroeconomic Indicators 27

4.5.1 Developing regions are expected to lead the future market 27

4.5.2 Growth of contract manufacturing in cell culture media 27

4.5.3 Rise of developing regions in muscle stimulator market 27

4.6 Mega Trends In cell culture media 28

4.6.1 Manufacturing 28

4.6.2 Substitution of serum or animal-derived components 28

5.1 Porter’s Five Forces Analysis 29

5.1.1 Threat from a New Entrant 30

5.1.2 Bargaining Power of Buyer 31

5.1.3 Bargaining Power of Supplier 31

5.1.4 Threat from substitute 32

5.1.5 Intensity of Competitive Rivalry 32

5.2 Supply Chain Analysis 33

5.2.1 Raw Material 33

5.2.2 Supplier 34

5.2.3 Manufacturer 34

5.2.4 Distributer 35

5.2.5 Customer-Retailer 35

5.2.6 Consumer 35

5.3 Investment Opportunity Analysis 36

5.3.1 Market size (current and future), growth rate and profitability 36

5.3.2 Product opportunity analysis 36

5.3.3 Geographic location analysis 37

5.3.4 Investment risks 37

5.3.5 Market outlook 38

5.3.6 Competitors 38

5.3.7 Projections 39

6.1 Introduction 40

6.2 lysogeny broth 42

6.3 Chemically defined media 42

6.4 Protein Free Media 43

6.5 Serum Free Media 43

6.6 Classical Media 44

6.7 Custom Media 44

7.1 Introduction 45

7.2 Drug Discovery 46

7.3 Toxicity Testing 47

7.4 Cancer Research 47

7.5 Genetic Engineering 48

7.6 Stem Cell Research 49

8.1 Introduction 50

8.2 Biotechnology & Pharmaceutical 51

8.3 Research Laboratories 52

8.4 Academic Institutes 52

8.5 Pathology Labs 53

9.1 Americas 55

9.1.1 US 58

9.1.2 Canada 61

9.1.3 Latin America 63

9.2 Europe 66

9.2.1 Germany 69

9.2.2 France 71

9.2.3 UK 74

9.2.4 Italy 76

9.2.5 Spain 79

9.2.6 Eastern Europe 81

9.3 Asia Pacific 84

9.3.1 Japan 87

9.3.2 China 90

9.3.3 India 92

9.3.4 Republic Of Korea 95

9.3.5 Australia 97

9.3.6 Rest Of Asia-Pacific 100

9.4 Middle East and Africa 103

9.4.1 Middle East 107

9.4.2 Africa 109

10.1 Merck KGaA 112

10.1.1 Company Overview 112

10.1.2 Financials 112

10.1.3 Products 112

10.1.4 Key Developments 112

10.2 Corning Incorporated 113

10.2.1 Company Overview 113

10.2.2 Financials 113

10.2.3 Products 113

10.2.4 Key Developments 113

10.3 GE Healthcare 114

10.3.1 Company Overview 114

10.3.2 Financials 114

10.3.3 Products 114

10.3.4 Key Developments 114

10.4 THERMO FISHER 115

10.4.1 Company Overview 115

10.4.2 Financials 115

10.4.3 Key Developments 115

10.5 Lonza 116

10.5.1 Company Overview 116

10.5.2 Financials 116

10.5.3 Key Developments 116

10.6 BD 117

10.6.1 Company Overview 117

10.6.2 Financials 117

10.6.3 Products 117

10.6.4 Key Developments 117

10.7 HiMedia Laboratories 118

10.7.1 Company Overview 118

10.7.2 Financials 118

10.7.3 Products 118

10.7.4 Products 118

11.1 Key Findings 119

11.1.1 CEO’s Viewpoint 119

11.1.2 Unmet Needs 119

11.1.3 Key Companies To Watch 119

11.1.4 Prediction 119

TABLE 1 GLOBAL CELL CULTURE MEDIA MARKET BY TYPE, USD MILLION, 2014-2023 40

TABLE 2 GLOBAL CELL CULTURE MEDIA MARKET FOR LYSOGENY BROTH, USD MILLION 2014-2023 42

TABLE 3 GLOBAL CELL CULTURE MEDIA MARKET FOR CHEMICALLY DEFINED MEDIA, USD MILLION 2014-2023 42

TABLE 4 GLOBAL CELL CULTURE MEDIA MARKET FOR PROTEIN FREE MEDIA, USD MILLION 2014-2023 43

TABLE 5 GLOBAL CELL CULTURE MEDIA MARKET FOR SERUM FREE MEDIA, USD MILLION 2014-2023 43

TABLE 6 GLOBAL CELL CULTURE MEDIA MARKET FOR CLASSICAL MEDIA, USD MILLION 2014-2023 44

TABLE 7 GLOBAL CELL CULTURE MEDIA MARKET FOR CUSTOM MEDIA, USD MILLION 2014-2023 44

TABLE 8 GLOBAL CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 45

TABLE 9 GLOBAL CELL CULTURE MEDIA MARKET FOR DRUG DISCOVERY AND DRUG DEVELOPMENT, USD MILLION 2014-2023 46

TABLE 10 GLOBAL CELL CULTURE MEDIA MARKET FOR TOXICITY TESTING, USD MILLION 2014-2023 47

TABLE 11 GLOBAL CELL CULTURE MEDIA MARKET FOR CANCER RESEARCH, USD MILLION 2014-2023 47

TABLE 12 GLOBAL CELL CULTURE MEDIA MARKET FOR GENETIC ENGINEERING, USD MILLION 2014-2023 48

TABLE 13 GLOBAL CELL CULTURE MEDIA MARKET FOR TISSUE ENGINEERING & BIOCHEMISTRY, USD MILLION 2014-2023 48

TABLE 14 GLOBAL CELL CULTURE MEDIA MARKET FOR STEM CELL RESEARCH, USD MILLION 2014-2023 49

TABLE 15 GLOBAL CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 50

TABLE 16 GLOBAL THE CELL CULTURE MEDIA MARKET FOR BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, USD MILLION 2014-2023 51

TABLE 17 GLOBAL THE CELL CULTURE MEDIA MARKET FOR RESEARCH LABORATORIES, USD MILLION 2014-2023 52

TABLE 18 GLOBAL THE CELL CULTURE MEDIA MARKET FOR ACADEMIC INSTITUTES, USD MILLION 2014-2023 52

TABLE 19 GLOBAL THE CELL CULTURE MEDIA MARKET FOR PATHOLOGY LABS, USD MILLION 2014-2023 53

TABLE 20 GLOBAL CELL CULTURE MEDIA MARKET BY REGION USD MILLION 2014-2023 54

TABLE 21 AMERICAS CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 56

TABLE 22 AMERICAS CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 57

TABLE 23 AMERICAS CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 57

TABLE 24 US CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 58

TABLE 25 US CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 59

TABLE 26 US CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 60

TABLE 27 CANADA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 61

TABLE 28 CANADA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 62

TABLE 29 CANADA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 62

TABLE 30 LATIN AMERICA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 63

TABLE 31 LATIN AMERICA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 64

TABLE 32 LATIN AMERICA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 65

TABLE 33 EUROPE CELL CULTURE MEDIA MARKET BY REGION USD MILLION 2014-2023 66

TABLE 34 EUROPE CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 67

TABLE 35 EUROPE CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 68

TABLE 36 EUROPE CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 68

TABLE 37 GERMANY CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 69

TABLE 38 GERMANY CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 70

TABLE 39 GERMANY CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 70

TABLE 40 FRANCE CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 71

TABLE 41 FRANCE CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 72

TABLE 42 FRANCE CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 73

TABLE 43 UK CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 74

TABLE 44 UK CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 75

TABLE 45 UK CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 75

TABLE 46 ITALY CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 76

TABLE 47 ITALY CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 77

TABLE 48 ITALY CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 78

TABLE 49 SPAIN CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 79

TABLE 50 SPAIN CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 80

TABLE 51 SPAIN CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 80

TABLE 52 EASTERN EUROPE CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 81

TABLE 53 EASTERN EUROPE CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 82

TABLE 54 EASTERN EUROPE CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 83

TABLE 55 ASIA PACIFIC CELL CULTURE MEDIA MARKET BY REGION USD MILLION 2014-2023 84

TABLE 56 ASIA PACIFIC CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 85

TABLE 57 ASIA PACIFIC CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 86

TABLE 58 ASIA PACIFIC CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 86

TABLE 59 JAPAN CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 87

TABLE 60 JAPAN CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 88

TABLE 61 JAPAN CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 89

TABLE 62 CHINA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 90

TABLE 63 CHINA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 91

TABLE 64 CHINA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 91

TABLE 65 INDIA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 92

TABLE 66 INDIA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 93

TABLE 67 INDIA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 94

TABLE 68 REPUBLIC OF KOREA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 95

TABLE 69 REPUBLIC OF KOREA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 96

TABLE 70 REPUBLIC OF KOREA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 96

TABLE 71 AUSTRALIA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 97

TABLE 72 AUSTRALIA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 98

TABLE 73 AUSTRALIA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 99

TABLE 74 REST OF ASIA-PACIFIC CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 100

TABLE 75 REST OF ASIA PACIFIC CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 101

TABLE 76 REST OF ASIA PACIFIC CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 102

TABLE 77 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET BY REGION USD MILLION 2014-2023 103

TABLE 78 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 104

TABLE 79 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 105

TABLE 80 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 106

TABLE 81 MIDDLE EAST CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 107

TABLE 82 MIDDLE EAST CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 108

TABLE 83 MIDDLE EAST CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 108

TABLE 84 AFRICA CELL CULTURE MEDIA MARKET BY TYPE USD MILLION 2014-2023 109

TABLE 85 AFRICA CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION 2014-2023 110

TABLE 86 AFRICA CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2014-2023 111

FIGURE 1 GLOBAL CELL CULTURE MEDIA MARKET BY TYPE MARKET SHARE 2016 (%) 12

FIGURE 2 GLOBAL CELL CULTURE MEDIA MARKET BY APPLICATIONS MARKET SHARE 2016 (%) 12

FIGURE 3 GLOBAL CELL CULTURE MEDIA MARKET BY END USERS MARKET SHARE 2016 (%) 13

FIGURE 4 CELL CULTURE MEDIA MARKET BY REGION MARKET SHARE 2016 (%) 14

FIGURE 5 GLOBAL CELL CULTURE MEDIA MARKET: MARKET STRUCTURE 16

FIGURE 6 RESEARCH PROCESS 17

FIGURE 7 FORECAST MODEL 20

FIGURE 8 PORTERS FIVE FORCES MODEL 29

FIGURE 9 GLOBAL CELL CULTURE MEDIA MARKET BY TYPE, USD MILLION, 2014-2023 41

FIGURE 10 GLOBAL CELL CULTURE MEDIA MARKET BY APPLICATIONS, USD MILLION, 2014-2023 46

FIGURE 11 GLOBAL CELL CULTURE MEDIA MARKET BY END USERS, USD MILLION 2016 & 2023 51

FIGURE 12 GLOBAL CELL CULTURE MEDIA MARKET BY REGION MARKET SHARE 2016 (%) 54

FIGURE 13 AMERICAS CELL CULTURE MEDIA MARKET BY REGION USD MILLION 2014-2023 55

FIGURE 14 AMERICAS CELL CULTURE MEDIA MARKET BY REGION MARKET SHARE 2016 (%) 55

FIGURE 15 EUROPE CELL CULTURE MEDIA MARKET BY REGION MARKET SHARE 2016 (%) 66

FIGURE 16 ASIA PACIFIC CELL CULTURE MEDIA MARKET BY REGION MARKET SHARE 2016 (%) 84

FIGURE 17 MIDDLE EAST AND AFRICA CELL CULTURE MEDIA MARKET BY MARKET SHARE 2016 (%) 103

Global Cell Culture Media Market: Competitive Landscape


In the global cell culture media market, major companies are opting for strategic partnerships and collaborations to strengthen their market position. Moreover, new product launches are the second most widely adopted a strategy by key market players. The key players involved in this strategy are Merck KGaA, Thermo Fisher Scientific, and GE Healthcare, among others.


Merck KGaA was established in the year 1968. With the 2015 merger of Sigma-Aldrich, Merck Millipore has a broad portfolio of 300,000 products and an expanded global footprint. The company is focused on product launches and partnerships to enhance its market presence. In May 2017, the company opened the first joint bioprocess scale-up lab with Stelis Biopharma in India. In the same year, Merck KGaA launched the first off-the-shelf cell culture media for perfusion processes.


GE Healthcare was incorporated in 1892. The company is engaged in strategic partnerships to increase its product portfolio and global presence. In April 2017, United BioPharma selected GE Healthcare’s FlexFactory to build late-stage clinical and commercial production capacity for biopharmaceuticals. In February 2017, the Austrian Centre of Industrial Biotechnology and GE Healthcare established a cell line engineering collaboration.


Thermo Fisher Scientific was founded in 1897. The company has adopted the new product launches strategy to hold its position in the global cell culture media market. In February 2017, Thermo Fisher Scientific launched the Gibco StemFlex Medium. Moreover,  in September 2017, the company launched enhancements to the Gibco B-27 Plus Neuronal Culture System.


Lonza was established in 1897 and is one of the world’s leading suppliers to the pharmaceutical, biotech, and specialty ingredients markets. In September 2017, Lonza introduced the CytoSMART2 System, an updated version of Lonza’s popular CytoSMART System for live cell imaging. Additionally, in March 2016, Lonza launched PowerCHO Advance Media.


These players established themselves as major companies across the globe. They are investing in research and development, awareness, marketing, and technology advancement. They also focus on acquisitions, partnerships, collaborations, expansions, and new product launches to obtain the maximum market share.